Assurance de qualité pour le cancer rectal – phase 2 ...

More documents

Recommendations

Info

98 PROCARE – phase 2 KCE reports 81Quality indicator Subdiscipline(s) Source Ex/inclusion Level Final QI(s)IF a patient has resection of a malignant tumour for stage II colonNICCQ Not rectalcancer with high risk for recurrence (obstruction, perforation, orT4 lesions) or stage III colon cancer and received chemotherapy,THEN the patient should start adjuvant chemotherapy within 8weeks of surgical resectionIF the patient has resection of stage II or III colon or rectal cancer,THEN the patient should be counseled about the need to havefirst-degree relatives undergo colorectal cancer screeningNICCQ Irrelevant* The subdiscipline and related final QI is only provided for the included QI.
KCE Reports 81 PROCARE – phase 2 99APPENDIX 2: ALGORITHMS OF SELECTEDQUALITY INDICATORSOVERALL 5-YEAR SURVIVAL AND DISEASE-SPECIFIC 5-YEARSURVIVAL (FIGURE 21)For the calculation of survival statistics, it is essential to include only those patients witha follow-up of the date of death. Mortality data are collected from the mortalitydatabase of the sickness funds, and are available until December 31 st 2006 for thepresent study. Coupling with the PROCARE database is done using the social securitynumber. Therefore, an accurate follow-up is only available for patients with a knownsocial security number and Belgian postal code. Since no mortality data are available forpatients with a private insurance, the survival is probably overestimated.Above this, to calculate the survival period between the incidence date (see below forthe definition of incidence date) and mortality date, it is of course essential to have theincidence date. Since mortality data are only available until December 31 st 2006, patientswith an incidence date after December 31 st 2006 are excluded.As explained in the scientific summary, the calculation of the disease-specific survival isimpossible at present, and the relative survival (i.e. observed survival / expectedsurvival) is calculated as a proxy. Expected survival rates were retrieved from themortality tables of 2004 (http://statbel.fgov.be/pub/home_nl.asp#3) and were linked tothe individual patient, taking into account age, gender and region.Figure 21. Algorithm for QI 1111 - 1112 (PROCARE database).All patientsN=1071All info availableN=1062Date of incidence≤ 31/12/2006N=866One of the following info missing?- National number- Incidence date- Belgian zipcodeDate of incidence≤ 31/12/2006?Date of incidence> 31/12/2006N=196Info missingN=9
Page 1 and 2:
Assurance de qualitépour le cancer
Page 3 and 4:
Assurance de qualité pour lecancer
Page 5 and 6:
KCE Reports 81B Cancer rectal - pha
Page 7:
KCE Reports 81B Cancer rectal - pha
Page 10 and 11:
vi Cancer rectal - phase 2 KCE Repo
Page 12 and 13:
2 PROCARE - phase 2 KCE reports 81A
Page 14 and 15:
4 PROCARE - phase 2 KCE reports 811
Page 16 and 17:
6 PROCARE - phase 2 KCE reports 81F
Page 19 and 20:
KCE Reports 81 PROCARE - phase 2 92
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58: KCE Reports 81 PROCARE - phase 2 47
Page 87 and 88: KCE Reports 81 PROCARE - Phase 2 77
Page 107: KCE Reports 81 PROCARE - phase 2 97
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169:
Page 172 and 173:
Dépôt légal : D/2008/10.273/39
Page 174 and 175:
35. Etude relative aux coûts poten
show all

Assurance de qualité pour le cancer rectal – phase 2 ...

Create successful ePaper yourself

Delete template?

Save as template?